When is endocervical curettage (ECC) recommended as part of the evaluation of postmenopausal vaginal bleeding? —Mary McCrossan, MD, Wilmington, Del. ECC is warranted in a woman with postmenopausal ...

Emily Fukuchi, MD; Barbara Fetterman, SCT (ASCP); Nancy Poitras, ACS, PMP; Walter Kinney, MD; Thomas Lorey, MD; Ramey D. Littell, MD To evaluate whether the presence of CIN 1 on ECC contributes to ...

When a woman has an abnormal pap smear she usually undergoes colposcopy. Typically a metal instrument is used to obtain a small sampling of cells inside the cervix -- an oftentimes painful procedure ...

Femasys Inc., a medical device developer of women's healthcare solutions, announced today the U.S. launch of the 510(k) cleared FemCerv™, an innovative endocervical curettage device. FemCerv is ...

ATLANTA, May 03, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by developing a suite of products and product candidates that include minimally ...

There are limited data and guidance from the UK on borderline nuclear change in endocervical cells (BNCs). The objective of this study is to determine the clinical outcome of women with BNCs, to ...

Objective. This study aimed to characterize the 24-month risk of cervical intraepithelial neoplasia grade 2 or worse (CIN 2+) and grade 3 or worse (CIN 3+) in women with low-risk cytological finding ...

- FemCerv® is the first endocervical tissue sampler designed to collect and contain a comprehensive sample to maximize quality and quantity - If a woman’s pap smear is abnormal, she generally needs to ...